These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34062216)

  • 1. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
    Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
    Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
    Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
    BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
    Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
    Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

  • 6. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
    Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2.
    Liu D; Chen C; Cui M; Zhang H
    Cancer Med; 2021 May; 10(10):3358-3372. PubMed ID: 33838016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
    Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
    Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.
    Zhou Y; Wu J; Fu X; Du W; Zhou L; Meng X; Yu H; Lin J; Ye W; Liu J; Peng H; Liu RY; Pan C; Huang W
    Mol Cancer; 2014 Nov; 13():258. PubMed ID: 25431208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
    Liu Z; Wang N; Wang F; Zhang S; Ding J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
    Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
    Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo.
    Sun L; Xue H; Jiang C; Zhou H; Gu L; Liu Y; Xu C; Xu Q
    Biosci Rep; 2016 Jun; 36(3):. PubMed ID: 26934980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
    Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.
    Wang Z; Jia L; Sun Y; Li C; Zhang L; Wang X; Chen H
    Front Mol Biosci; 2021; 8():682594. PubMed ID: 34179087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.